Kewaunee Q1 Earnings Fall Y/Y Despite International Strength

Kewaunee Scientific Corporation (KEQU) reported first-quarter fiscal 2027 earnings per share of $0.58, down from $1.04 in the prior-year period, as revenue declined 6.7% to $66.3 million. The miss reflects pressure in the company's Lab Products Group, where challenging life sciences market conditions crimped domestic sales.

The International segment provided a partial offset, delivering improved profitability through a higher-margin project mix. Management attributed the overall revenue decline to extended project timelines driven by geopolitical and economic uncertainty, though the company maintains confidence in underlying demand trends.

The year-over-year EPS decline of approximately 44% represents a significant compression in profitability despite relatively modest top-line erosion, suggesting margin pressure beyond simple volume effects in the domestic lab equipment business.